Recent FDA approval of acamprosate (Campral(r)) and long-acting injectable naltrexone (Vivitrol(r)) has given alcohol treatment providers and their patients'new treatment options in addition to existing pharmacotherapies and psychosocial counseling techniques for the treatment of alcohol dependence. In addition, the evidence base continues to accumulate for a number of counseling techniques such as motivational interviewing and contingency management, and manualized approaches are being developed and disseminated. Coupled with these developments in treatment "technologies" is an ever-increasing emphasis by states and payers on the use of evidence-based practices. Together, these factors are beginning to influence changes in the content of treatment services. However, there remain significant concerns about the effective dissemination of these evidence-based treatment techniques and the elimination of the "research to practice gap" that characterizes much of the addiction treatment field. There are few mechanisms to measure the effectiveness of various dissemination strategies, the extent of adoption of evidence-based innovations, and the fidelity with which those techniques are implemented in diverse, real-world treatment settings. Moreover, there is scant research on the organizational, staffing, and environmental factors that facilitate or impede the diffusion, adoption, and implementation of evidence-based behavioral and pharmacological approaches to alcoholism treatment. The economic disincentives to integrating new practices in treatment organizations and counselor repertoires likewise require study. To address these needs, we propose a longitudinal data collection effort with N=400 alcohol treatment centers from which related data were collected in 2001-2006. Longitudinal data in hand provide a valuable baseline against which to monitor future adoption behaviors of existing techniques, diffusion of emerging treatment innovations, and discontinuation of previously-used methods. Because the baseline data include a period of time before the approval of acamprosate and Vivitrol, this study would offer a unique opportunity to monitor past, present, and future adoption of these medications specifically, and related treatment strategies more generally.

National Institute of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Research Project (R01)
Project #
Application #
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Lowman, Cherry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Georgia
Social Sciences
Schools of Arts and Sciences
United States
Zip Code
Paino, Maria; Aletraris, Lydia; Roman, Paul M (2015) Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment. Subst Abus 36:462-9
Knudsen, Hannah K; Roman, Paul M (2015) Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations. J Subst Abuse Treat 49:7-Jan
Abraham, Amanda J; Knudsen, Hannah K; Roman, Paul M (2014) The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment. J Subst Abuse Treat 46:232-7
Aletraris, Lydia; Paino, Maria; Edmond, Mary Bond et al. (2014) The use of art and music therapy in substance abuse treatment programs. J Addict Nurs 25:190-6
Knudsen, Hannah K; Roman, Paul M (2014) Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders. J Stud Alcohol Drugs 75:467-75
Abraham, Amanda J; O'Brien, Lauren A; Knudsen, Hannah K et al. (2013) Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat 44:120-5
Abraham, Amanda J; Knudsen, Hannah K; Rieckmann, Traci et al. (2013) Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. J Stud Alcohol Drugs 74:258-65
Savage, Sarah A; Abraham, Amanda J; Knudsen, Hannah K et al. (2012) Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages. J Subst Abuse Treat 42:16-24
Abraham, Amanda J; O'Brien, Lauren A; Bride, Brian E et al. (2011) HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend 115:16-22
Roman, Paul M; Abraham, Amanda J; Knudsen, Hannah K (2011) Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav 36:584-9

Showing the most recent 10 out of 14 publications